Ambion and Rosetta Genomics have announced a licensing and
commercialisaton agreement to advance microRNA research. The
results will facilitate microRNA research that hails this as a
promising area in the treatment of a range of diseases.
Biotechnology firm, MorphoSys, have announced an agreement with
pharmaceutical company Shionogi, in a deal that fits into
MorphoSys' effort to expand geographically into the Japanese market
- currently the second largest individual...
Anglo-German company Evotec has reorganised its pharmaceutical
development services business by integrating its ProPharma
subsidiary, based in Scotland, into a new structure alongside its
Akzo Nobel business unit Diosynth, which specialises in the
production of complex active biopharmaceutical ingredients for the
pharmaceutical sector, has won a contract to apply its new method
for manufacturing synthetic peptides...
French drug delivery company Flamel Technologies suffered another
blow yesterday when it was revealed that TAP Pharmaceutical
Products has pulled out of deal to develop a formulation of its
big-selling gastrointestinal drug lansoprazole...
Following hot on the heels of the GSK's expansion of its vaccine
division, Novartis is seeking to take control of vaccine maker
Chiron by buying the remaining shares it does not already own in
the US firm for $4.5bn (£2.5bn).
The cost-effective benefits and research standards set to become
international has added to the attraction of outsourcing R&D to
India and China - two developing nations that are set to ease the
ever-increasing cost pressures,...
Affiliated Computer Services (ACS), announced today that it has
been awarded an additional information technology (IT) outsourcing
contract with GlaxoSmithKline (GSK), valued at $100.5 million (€82
million) over five years.
Charles River Laboratories saw a double digit boost in fiscal
second quarter revenues with a leap in operating earnings, helped
by its acquisition of Inveresk Research Group, and also to
continuing strong demand for research models...
Labcyte has announced that it has closed its latest round of
financing in which $21 milllion was raised. The funds will be used
to expand its low-volume liquid handling business with a view to
marketing the next Labcyte product in...
Pfizer has revealed that it is set to outsource some of its
technology jobs to India, harnessing the country's IT
infrastructure to focus more on clinical trial and other
R&D-related information management.